S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
NASDAQ:BLRX

BioLineRx - BLRX Earnings Date, Estimates & Call Transcripts

$0.62
-0.01 (-1.59%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.60
$0.63
50-Day Range
$0.57
$0.74
52-Week Range
$0.55
$1.98
Volume
273,635 shs
Average Volume
268,827 shs
Market Capitalization
$37.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Earnings Summary

Upcoming
Earnings Date
Mar. 15Estimated
Actual EPS
(Nov. 15)
-$0.15 Beat By $0.01
Consensus EPS
(Nov. 15)
-$0.16
Last Year's Q4 EPS
(11/18/2021)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

BLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLineRx Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.12)($0.12)($0.12)
Q2 20231($0.12)($0.12)($0.12)
Q3 20231($0.14)($0.14)($0.14)
Q4 20231($0.12)($0.12)($0.12)
FY 20234($0.50)($0.50)($0.50)

BLRX Earnings Date and Information

BioLineRx last announced its earnings data on November 15th, 2022. The biotechnology company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.01. BioLineRx has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for BioLineRx are expected to grow in the coming year, from ($0.54) to ($0.48) per share. BioLineRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 15th, 2023 based off prior year's report dates.

BioLineRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/15/2023
(Estimated)
        
11/15/2022Q3 2022($0.16)($0.15)+$0.01($0.15)
8/16/2022Q2 2022($0.14)($0.16)($0.02)($0.16)
5/11/2022Q1 2022($0.15)($0.10)+$0.05($0.10)
3/16/2022Q4 2021($0.14)($0.08)+$0.06($0.08)
12/8/2021Q3($0.16)($0.15)+$0.01  
11/18/2021Q3 2021($0.13)($0.23)($0.10)($0.23)
8/18/2021Q2($0.12)($0.15)($0.03)($0.15)    
5/26/2021Q1 2021($0.15)($0.27)($0.12)($0.27)
2/23/2021Q4 2020($0.25)($0.61)($0.36)($0.61)
11/23/20209/30/2020($0.36)($0.30)+$0.06($0.30)  
8/6/2020Q2 2020($0.60)($0.45)+$0.15($0.45)
5/20/2020Q1 2020($0.83)($0.60)+$0.23($0.60)
3/12/2020Q4 2019($0.64)($0.97)($0.33)($0.97)  
11/11/2019Q3 2019($0.67)($0.40)+$0.27($0.40)
8/6/2019Q2($0.65)($0.04)+$0.61($0.04)
5/14/20193/31/2019($0.05)($0.05)($0.05)
3/28/201912/31/2018($0.09)($0.05)+$0.04($0.05)
11/8/20189/30/2018($0.06)($0.06)($0.06)
8/13/2018Q2 2018($0.06)($0.05)+$0.01($0.05)
5/22/20183/31/2018($0.07)($0.06)+$0.01($0.06)  
3/6/2018Q4 2017($0.06)($0.07)($0.01)($0.07)
11/21/2017Q3 2017($0.05)($0.07)($0.02)($0.07)
8/8/20176/30/2017($0.05)($0.05)($0.05)$0.01 million  
5/25/20173/31/2017($0.05)($0.08)($0.03)($0.08)$0.01 million
3/23/201712/31/2016($0.08)($0.13)($0.05)($0.13)$0.02 million
11/22/2016Q316($0.07)($0.08)($0.01)($0.08)
8/11/2016Q216($0.07)($0.07)($0.07)  
5/17/2016Q116($0.08)($0.10)($0.02)($0.10)  
3/10/2016Q415($0.06)($0.07)($0.01)($0.07)  
11/16/2015Q315($0.08)($0.03)+$0.05($0.03)  
8/20/2015Q215($0.10)($0.09)+$0.01($0.09)  
5/18/2015Q115($0.10)($0.08)+$0.02($0.08)  
4/13/2015Q4 2014($0.10)($0.11)($0.01)($0.11)
11/10/2014Q314($0.11)($0.02)+$0.09($0.02)
8/6/2014Q214($0.09)($0.12)($0.03)($0.12)
5/20/2014Q114($0.11)($0.01)+$0.10($0.10)  
3/17/2014Q4 2013($0.18)($0.20)($0.02)($0.20)
11/13/2013Q3 2013($0.18)($0.20)($0.02)($0.20)
8/6/2013Q2 2013($0.15)($0.20)($0.05)($0.20)
5/7/2013Q1 2013($0.02)($0.20)($0.18)($0.20)  
3/12/2013Q4 2012($0.29)($0.30)($0.01)($0.30)
11/14/2012Q312($0.15)($0.15)  
8/15/2012Q2 2012($0.25)($0.02)+$0.23($0.02)
5/15/2012Q1 2012($0.30)($0.30)($0.30)
3/22/2012Q4 2011($0.30)($0.30)($0.30)
11/29/2011Q3 2011($0.20)($0.20)($0.20)
8/23/2011Q2 2011($0.40)($0.40)($0.40)












BioLineRx Earnings - Frequently Asked Questions

When is BioLineRx's earnings date?

BioLineRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 15th, 2023 based off last year's report dates. Learn more on BLRX's earnings history.

Did BioLineRx beat their earnings estimates last quarter?

In the previous quarter, BioLineRx (NASDAQ:BLRX) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.01. Learn more on analysts' earnings estimate vs. BLRX's actual earnings.

How much profit does BioLineRx generate each year?

BioLineRx (NASDAQ:BLRX) has a recorded net income of -$27.05 million. BLRX has generated -$0.49 earnings per share over the last four quarters.

What is BioLineRx's EPS forecast for next year?

BioLineRx's earnings are expected to grow from ($0.54) per share to ($0.48) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:BLRX) was last updated on 2/7/2023 by MarketBeat.com Staff